A Novel Cognitive Remediation Intervention Targeting Poor Decision-Making and Depression in Veterans at High Risk for Suicide: A Safe,Telehealth Approach During the COVID-19 Pandemic
A Novel Cognitive Remediation Intervention Targeting Poor Decision-Making and Depression in Veterans at High Risk for Suicide: A Safe,Telehealth Approach During the COVID-19 Pandemic
批准号:
10366431
负责人:
ERIN A. HAZLETT
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-01-01 至 2023-12-31
关键词:
AddressAftercareBehaviorBehavioralCOVID-19COVID-19 impactCOVID-19 pandemicCOVID-19 pandemic effectsClient satisfactionClinicalCognitiveCognitive TherapyCognitive remediationDataDecision MakingElderlyEmotionsEvaluationExecutive DysfunctionFeeling suicidalGamblingGoalsImpairmentIndividualInterventionIntervention StudiesIowaLanguageMajor Depressive DisorderMeasuresMental DepressionMental disordersNamesNeurocognitiveNeurocognitive DeficitNeuronal PlasticityNeuropsychologyParticipantPatientsPatternPerformancePilot ProjectsProblem SolvingPublic HealthQuality of lifeQuestionnairesRecording of previous eventsRecoveryRehabilitation therapyReportingRisk FactorsSamplingSchizophreniaSemanticsServicesSeveritiesSocial AdjustmentSocial DistanceSuicideSuicide attemptTestingTherapeutic InterventionThinkingTimeVeteransWorkacceptability and feasibilitybasecognitive controlcognitive functioncognitive rehabilitationcognitive skillcognitive testingdaily functioningdepressive symptomsevidence baseexecutive functionfeasibility testingfollow up assessmentfollow-uphigh riskimplementation interventionimprovedinnovationmilitary veterannovelrecruitresponseskillssocialstressorsuicidal behaviorsuicidal risksymptomatologytargeted treatmenttelehealththerapy developmenttooltreatment as usualvirtual
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
Despite large-scale, nationwide efforts to better address suicidal behavior (defined as thoughts and
behavior) in high-risk Veterans with major depressive disorder (MDD), the development of interventions that
target some of the key risk factors associated with suicide in Veterans with MDD remains limited. That is, while
much intervention research continues to investigate treatments like cognitive behavioral therapy (CBT) that
target behavioral patterns, emotion processing problems, and cognitive styles associated with suicide risk in
MDD, deficits in the neurocognitive substrates that underlie these CBT targets remain under-addressed.
Cognitive remediation (CR) and rehabilitation have long been a primary treatment for patients with other
psychiatric illnesses, like schizophrenia, for improving cognitive functioning and facilitating transfer of cognitive
skills to every-day functioning. However, scant work has examined CR that addresses the neurocognitive
deficits underlying suicidal behavior in individuals with MDD. Empirical work has identified key executive
functioning (EF) deficits that may be specific to MDD patients with suicidal behavior, and meta-analytic work
indicates that CR has moderate effect sizes on cognitive functioning, depression, and daily functioning in MDD.
Thus, the field is in dire need of work that examines CR as a recovery-oriented treatment approach for MDD
patients at risk for suicide.
The proposed study aims to collect pilot data to test the feasibility and acceptability of adjunctive
neuroplasticity-based CR on key treatment targets delivered via telehealth during this time of COVID-19 in a
sample of 36 Veterans with MDD and a history of suicide attempt(s). Specifically, it will test the effects of an
adjunctive evidence-based cognitive remediation (CR) therapy (adjunctive to treatment as usual) augmented
with manualized “Bridging” sessions on transfer and practice of cognitive control and decision-making/problem-
solving strategies for real-world situations and problems, including those that trigger suicidal thoughts. We
propose to administer the Neuropsychological Educational Approach to Cognitive Remediation (NEAR, termed
CR plus “Bridging” session, CR+Bridging) to a total of 36 Veterans with MDD and a history of suicide
attempt(s). The intervention will be delivered in 20 90-minute sessions (2x/week for 10 weeks). Pre-treatment
assessments of neurocognitive, clinical, social, and real-world functioning will be conducted, including
measures that examine the impact of COVID-19 and its accompanying “social-distancing” restrictions. Post-
treatment assessments of the same targets will be conducted to determine clinical response to and feasibility
of this therapeutic intervention immediately following conclusion of the intervention (Week 10) and at a follow-
up assessment (Week 20). This application is novel in that it constitutes the first implementation of this
intervention in Veterans with MDD and suicidal behavior. Consistent with RR&D’s SPiRE mechanism, this
study is high risk, but it has high potential impact and promise to help improve quality of life for Veterans at
high risk for suicide.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CSRD Research Career Scientist Award Application
-
批准号:10701136
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2023
-
负责人:ERIN A. HAZLETT
-
依托单位:
A Novel Cognitive Remediation Intervention Targeting Poor Decision-Making and Depression in Veterans at High Risk for Suicide: A Safe,Telehealth Approach During the COVID-19 Pandemic
-
批准号:10539275
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2022
-
负责人:ERIN A. HAZLETT
-
依托单位:
Longitudinal neuroimaging and neurocognitive assessment of risk and protective factors across the schizophrenia spectrum
-
批准号:10542376
-
项目类别:
-
资助金额:$100.32万
-
财政年份:2020
-
负责人:ERIN A. HAZLETT
-
依托单位:
Longitudinal neuroimaging and neurocognitive assessment of risk and protective factors across the schizophrenia spectrum
-
批准号:10381940
-
项目类别:
-
资助金额:$20.68万
-
财政年份:2020
-
负责人:ERIN A. HAZLETT
-
依托单位:
Longitudinal neuroimaging and neurocognitive assessment of risk and protective factors across the schizophrenia spectrum
-
批准号:10319171
-
项目类别:
-
资助金额:$99.89万
-
财政年份:2020
-
负责人:ERIN A. HAZLETT
-
依托单位:
CSR&D Research Career Scientist Award Application
-
批准号:10177966
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:ERIN A. HAZLETT
-
依托单位:
CSR&D Research Career Scientist Award Application
-
批准号:10426091
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:ERIN A. HAZLETT
-
依托单位:
CSR&D Research Career Scientist Award Application
-
批准号:9892965
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:ERIN A. HAZLETT
-
依托单位:
CSR&D Research Career Scientist Award Application
-
批准号:9551820
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:ERIN A. HAZLETT
-
依托单位:
Neurobiology of Affective Instability in Veterans at Low and High Risk for Suicide
-
批准号:10311973
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2017
-
负责人:ERIN A. HAZLETT
-
依托单位:
Neurobiology of Affective Instability in Veterans at Low and High Risk for Suicide
-
批准号:9892959
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2017
-
负责人:ERIN A. HAZLETT
-
依托单位:
Selecting Best Neuroleptic Treatment for Veterans with Schizophrenia
-
批准号:8392955
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:ERIN A. HAZLETT
-
依托单位:
Selecting Best Neuroleptic Treatment for Veterans with Schizophrenia
-
批准号:8142659
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:ERIN A. HAZLETT
-
依托单位:
Selecting Best Neuroleptic Treatment for Veterans with Schizophrenia
-
批准号:8277786
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:ERIN A. HAZLETT
-
依托单位:
NEURAL SUBSTRATES OF EMOTION IN BORDERLINE PATIENTS
-
批准号:7953684
-
项目类别:
-
资助金额:$0.07万
-
财政年份:2009
-
负责人:ERIN A. HAZLETT
-
依托单位:
NEURAL SUBSTRATES OF EMOTION IN BORDERLINE PATIENTS
-
批准号:7718165
-
项目类别:
-
资助金额:$2.05万
-
财政年份:2008
-
负责人:ERIN A. HAZLETT
-
依托单位:
NEURAL SUBSTRATES OF EMOTION REGULATION IN HEALTHY INDIVIDUALS
-
批准号:7718192
-
项目类别:
-
资助金额:$0.06万
-
财政年份:2008
-
负责人:ERIN A. HAZLETT
-
依托单位:
NEURAL SUBSTRATES OF EMOTION IN BORDERLINE PATIENTS
-
批准号:7605350
-
项目类别:
-
资助金额:$2.61万
-
财政年份:2007
-
负责人:ERIN A. HAZLETT
-
依托单位:
Neural Substrates of Emotion in Borderline Patients
-
批准号:7342829
-
项目类别:
-
资助金额:$37.03万
-
财政年份:2006
-
负责人:ERIN A. HAZLETT
-
依托单位:
Neural Substrates of Emotion in Borderline Patients
-
批准号:7171852
-
项目类别:
-
资助金额:$37.03万
-
财政年份:2006
-
负责人:ERIN A. HAZLETT
-
依托单位:
海外基金